ESTA Establishment Labs
- 58.810
- +2.620+4.66%
- 57.340
- -1.470-2.50%
Establishment Labs News
Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK), AbbVie (ABBV) and Establishment Labs Holdings (ESTA)
Establishment Labs Holdings Inc (ESTA) Q1 2024 Earnings: Misses Revenue Estimates
Analysts Offer Insights on Healthcare Companies: Establishment Labs Holdings (ESTA) and Cytokinetics (CYTK)
Establishment Labs | 10-Q: Quarterly report
Earnings Call Summary | Establishment Labs(ESTA.US) Q1 2024 Earnings Conference
The following is a summary of the Establishment Labs Holdings Inc. (ESTA) Q1 2024 Earnings Call Transcript:Financial Performance:Establishment Labs reported Q1 revenue of $37.2 million, and an adjuste
Establishment Labs: A Strong Buy on Robust Q1 Performance and Strategic Market Expansion
Establishment Labs Holdings Inc. (ESTA) Reports Q1 Loss, Tops Revenue Estimates
Establishment Labs Backs 2024 Rev $174M-$184M >ESTA
Establishment Labs Backs 2024 Rev $174M-$184M >ESTA
Establishment Labs Hldgs Q1 2024 Adj EPS $(0.58) Beats $(0.67) Estimate, Sales $37.200M Beat $36.001M Estimate
Establishment Labs Hldgs (NASDAQ:ESTA) reported quarterly losses of $(0.58) per share which beat the analyst consensus estimate of $(0.67) by 13.43 percent. The company reported quarterly sales of $3
Earnings Flash (ESTA) ESTABLISHMENT LABS HOLDINGS Posts Q1 Revenue $37.2M, Vs. Street Est of $35.5M
04:00 PM EDT, 05/08/2024 (MT Newswires) -- Earnings Flash (ESTA) ESTABLISHMENT LABS HOLDINGS Posts Q1 Revenue $37.2M, vs. Street Est of $35.5M
Establishment Labs 1Q Rev $37.2M >ESTA
Establishment Labs 1Q Rev $37.2M >ESTA
Establishment Labs 1Q Loss/Shr 58c >ESTA
Establishment Labs 1Q Loss/Shr 58c >ESTA
Establishment Labs Notes Presentation of 4-Year Results From Motiva U.S. IDE Study at The Aesthetic Meeting 2024
Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, noted the presentation today
Establishment Labs Announces Appointment of Jeff Ehrhardt as General Manager of North America
Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, announced today that Jeff
Establishment Labs to Announce First Quarter 2024 Financial Results on May 8
Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, plans to announce its
Establishment Labs Announces Participation in The Aesthetic Meeting 2024
Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced its
Establishment Labs Is Maintained at Buy by Citigroup
Establishment Labs Is Maintained at Buy by Citigroup
Citigroup Maintains Buy on Establishment Labs Hldgs, Raises Price Target to $60
Citigroup analyst Joanne Wuensch maintains Establishment Labs Hldgs with a Buy and raises the price target from $49 to $60.
Analysts Offer Insights on Healthcare Companies: Establishment Labs Holdings (ESTA) and Gritstone Oncology (GRTS)
Establishment Labs Says US FDA Schedules Preapproval Inspection of Motiva Implants Facility
Establishment Labs (ESTA) said Tuesday that the US Food and Drug Administration scheduled a PMA preapproval inspection of the company's manufacturing facility for Motiva Implants. The inspection is se
Analysis
Price Target
No Data
